Literature DB >> 12420373

[TPD ophthalmic solution (mixture of tropicamide, phenylephrine hydrochloride, and diclofenac sodium) for cataract surgery].

Takao Hirowatari1, Kazuhiro Tokuda, Yuko Kamei, Yasunori Miyazaki, Masao Matsubara.   

Abstract

PURPOSE: We made a TPD ophthalmic solution by combining tropicamide solution(Mydrin-P: T), phenylephrine hydrochloride(Neosynesin Kowa: P) and diclofenac sodium(Diclod: D), and evaluated its efficiency in mydriasis during cataract surgery compared to T, P, and D. SUBJECTS AND METHODS: Twenty-five eyes(19 patients) were given either TPD solution(10 eyes) or T, P, and D solution(15 eyes), and the treatment was given six times before surgery. Pupil diameters were measured before and after surgery. RESULT: The operation time was 10.0 +/- 5.2(mean +/- standard deviation) minutes in the TPD group, and 9.0 +/- 3.6 minutes in the T, P and D group. The preoperative and postoperative one pupil diameter was 8.65 +/- 0.34 mm and 8.20 +/- 0.35 mm in the TPD group and 8.80 +/- 0.49 mm and 8.37 +/- 0.61 mm in the T, P, and D group, respectively. The rate of miosis was 5.1 +/- 4.2% in the TPD group and 4.8 +/- 5.1% in the T, P, and D group, respectively. There was no statistically significant difference between the two groups.
CONCLUSION: TPD ophthalmic solution maintains the mydriasis as potent by as T, P and D solution.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12420373

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  1 in total

1.  Randomised controlled single-blind study of conventional versus depot mydriatic drug delivery prior to cataract surgery.

Authors:  Vincent Dubois; Nadia Wittles; Meon Lamont; Simon Madge; Jon Luck
Journal:  BMC Ophthalmol       Date:  2006-11-27       Impact factor: 2.209

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.